greeksoup/ stock research

National Healthcare (NHC) FY2024 results: revenue $1.3 billion, up 14.5% on the year

National Healthcare Corp. (NHC) reported revenue of $1.3 billion for fiscal 2024, the year ended 31 December 2024, up 14.5% on the year before. Net income was $102 million, up 52.6%, and diluted earnings per share $6.53. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2025.

Revenue
$1.3 billion
+14.5% on the year
FY2017FY2024
Operating margin
6.9%
5.0% a year earlier
FY2017FY2024
Net income
$102 million
+52.6% on the year
FY2017FY2024
Diluted EPS
$6.53
+50.5% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue1,3071,1421,086+14.5%
Operating income89.957.531.9+56.5%
Operating margin6.9%5.0%2.9%
Interest expense4.10.30.6+1,176.2%
Pre-tax income13688.727.2+53.7%
Income tax34.323.47.3+46.4%
Effective tax rate25.2%26.4%26.6%
Net income10266.822.4+52.6%
Net margin7.8%5.9%2.1%
Diluted EPS$6.53$4.34$1.45+50.5%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow1071118.7-3.5%
Capital expenditure27.627.930.2-1.1%
Free cash flow79.783.3-21.5-4.3%
Free cash flow margin6.1%7.3%-2.0%
Cash from investing-237-17.6-6.0
Cash from financing100-42.5-47.6
Depreciation and amortisation42.042.040.5-0.1%
Share-based compensation4.22.82.6+49.5%
Buybacks13.52.59.9+444.0%
Dividends paid37.035.634.6+3.9%
Dividend per share$2.42$2.34$2.26+3.4%
Diluted shares, weighted16m15m15m+1.4%
Shares outstanding at period end15m15m15m+0.6%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity980909874+7.9%
Non-controlling interest3.01.73.2+73.7%
Debt1370.00.0
Operating lease liabilities45.963.291.0-27.3%
Finance lease liabilitiesn/a0.00.9
Other liabilities358337306+6.3%
Total liabilities and equity1,5241,3111,275+16.3%
Fixed assets684493507+38.7%
Goodwill170168168+1.3%
Intangible assets19.97.07.0+182.2%
Securities held for sale or to maturity120128143-6.2%
Cash and equivalents76.110758.7-28.9%
Receivables135109100.0+24.7%
Inventory9.07.47.1+22.4%
Other assets310291285+6.2%
Total assets1,5241,3111,275+16.3%

10-K for the year ended 31 December 2024, filed 28 February 2025: the filing.